The Most-Cited Articles on Retinoblastoma: A Fifty-Year Perspective
Abstract
:1. Introduction
2. Methods
Statistical Analysis
3. Results
3.1. Authorship
3.2. Number of Patients
3.3. Category
3.4. Topics
3.5. The Ten Most Cited Papers
4. Discussion
4.1. Authorship and Number of Patients
4.2. Category
4.3. Topics
4.4. The Ten Most Cited Papers
4.5. Publication Time
4.6. Study Limitations
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Dimaras, H.; Kimani, K.; Dimba, E.A.; Gronsdahl, P.; White, A.; Chan, H.S.; Gallie, B.L. Retinoblastoma. Lancet 2012, 379, 1436–1446. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Seregard, S.; Lundell, G.; Svedberg, H.; Kivelä, T. Incidence of retinoblastoma from 1958 to 1998 in Northern Europe: Advantages of birth cohort analysis. Ophthalmology 2004, 111, 1228–1232. [Google Scholar] [CrossRef] [PubMed]
- Parma, D.; Ferrer, M.; Luce, L.; Giliberto, F.; Szijan, I. RB1 gene mutations in Argentine retinoblastoma patients. Implications for genetic counseling. PLoS ONE 2017, 12, e0189736. [Google Scholar] [CrossRef] [PubMed]
- Wyse, E.; Handa, J.T.; Friedman, A.D.; Pearl, M.S. A review of the literature for intra-arterial chemotherapy used to treat retinoblastoma. Pediatr. Radiol. 2016, 46, 1223–1233. [Google Scholar] [CrossRef] [PubMed]
- Ancona-Lezama, D.; Dalvin, L.A.; Shields, C.L. Modern treatment of retinoblastoma: A 2020 review. Indian J. Ophthalmol. 2020, 68, 2356. [Google Scholar] [CrossRef]
- Dittner Moormann, S.; Reschke, M.; Abbink, F.C.; Aerts, I.; Atalay, H.T.; Fedorovna Bobrova, N.; Biewald, E.; Brecht, I.B.; Caspi, S.; Cassoux, N.; et al. Adjuvant therapy of histopathological risk factors of retinoblastoma in Europe: A survey by the European Retinoblastoma Group (EURbG). Pediatr. Blood Cancer 2021, 68, e28963. [Google Scholar] [CrossRef]
- Kiss, S.; Leiderman, Y.I.; Mukai, S. Diagnosis, classification, and treatment of retinoblastoma. Int. Ophthalmol. Clin. 2008, 48, 135–147. [Google Scholar] [CrossRef] [Green Version]
- Abramson, D.H. Retinoblastoma in the 20th century: Past success and future challenges the Weisenfeld lecture. Investig. Ophthalmol. Vis. Sci. 2005, 46, 2684–2691. [Google Scholar] [CrossRef] [Green Version]
- Singh, G.; Daniels, A.B. Disparities in retinoblastoma presentation, treatment, and outcomes in developed and less-developed countries. Semin. Ophthalmol. 2016, 31, 310–316. [Google Scholar] [CrossRef]
- Girdler, H.; Flegg, K.; Prochaska, J.; Dimaras, H. Characterization of international partnerships in global retinoblastoma care and research: A network analysis. PLOS Glob. Public Health 2021, 1, e0000125. [Google Scholar] [CrossRef]
- Shields, C.L.; Bas, Z.; Laiton, A.; Silva AM, V.; Sheikh, A.; Lally, S.E.; Shields, J.A. Retinoblastoma: Emerging concepts in genetics, global disease burden, chemotherapy outcomes, and psychological impsact. Eye 2022, 37, 815–822. [Google Scholar] [CrossRef]
- Fabian, I.D.; Onadim, Z.; Karaa, E.; Duncan, C.; Chowdhury, T.; Scheimberg, I.; Ohnuma, S.-I.; Reddy, M.A.; Sagoo, M.S. The management of retinoblastoma. Oncogene 2018, 37, 1551–1560. [Google Scholar] [CrossRef]
- Agarwal, A.; Thaker, N.G.; Tawk, B.; Allen, P.K.; Grosshans, D.R.; Herzog, C.E.; Gombos, D.S.; Mahajan, A. The evolution of radiation therapy for retinoblastoma: The MD Anderson cancer center experience. Int. J. Part. Ther. 2016, 2, 490–498. [Google Scholar] [CrossRef]
- Francis, J.H.; Roosipu, N.; Levin, A.M.; Brodie, S.E.; Dunkel, I.J.; Gobin, Y.P.; Abramson, D.H. Current treatment of bilateral retinoblastoma: The impact of intraarterial and intravitreous chemotherapy. Neoplasia 2018, 20, 757–763. [Google Scholar] [CrossRef]
- Sastre, X.; Chantada, G.L.; Doz, F.; Wilson, M.W.; De Davila, M.T.; Rodríguez-Galindo, C.; Chintagumpala, M.; Chévez-Barrios, P. Proceedings of the consensus meetings from the International Retinoblastoma Staging Working Group on the pathology guidelines for the examination of enucleated eyes and evaluation of prognostic risk factors in retinoblastoma. Arch. Pathol. Lab. Med. 2009, 133, 1199–1202. [Google Scholar] [CrossRef]
- Shields, C.L.; Shields, J.A. Retinoblastoma management: Advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy. Curr. Opin. Ophthalmol. 2010, 21, 203–212. [Google Scholar] [CrossRef]
- Yousef, Y.A.; Soliman, S.E.; Astudillo, P.P.; Durairaj, P.; Dimaras, H.; Chan, H.S.L.; Héon, E.; Gallie, B.L.; Shaikh, F. Intra-arterial chemotherapy for retinoblastoma: A systematic review. JAMA Ophthalmol. 2016, 134, 584–591. [Google Scholar] [CrossRef]
- Gobin, Y.P.; Dunkel, I.J.; Marr, B.P.; Francis, J.H.; Brodie, S.E.; Abramson, D.H. Combined, sequential intravenous and intra-arterial chemotherapy (bridge chemotherapy) for young infants with retinoblastoma. PLoS ONE 2012, 7, e44322. [Google Scholar] [CrossRef]
- Ghose, S.; Nizamuddin SH, M.; Sethi, A.; Mohanti, B.K.; Kumar, H.; Arya, L.S.; Thavaraj, V. Efficacy of induction chemotherapy in retinoblastoma, alone or combined with other adjuvant modalities. J. Pediatr. Ophthalmol. Strabismus 2002, 39, 143–150. [Google Scholar] [CrossRef]
- Draper, G.J.; Sanders, B.M.; Kingston, J.E. Second primary neoplasms in patients with retinoblastoma. Br. J. Cancer 1986, 53, 661–671. [Google Scholar] [CrossRef] [Green Version]
- Wong, F.L.; Boice, J.D.; Abramson, D.H.; Tarone, R.E.; Kleinerman, R.A.; Stovall, M.; Goldman, M.B.; Seddon, J.M.; Tarbell, N.; Fraumeni, J.F. Cancer incidence after retinoblastoma: Radiation dose and sarcoma risk. JAMA 1997, 278, 1262–1267. [Google Scholar] [CrossRef] [PubMed]
- Warda, O.; Naeem, Z.; Roelofs, K.A.; Sagoo, M.S.; Reddy, M. Retinoblastoma and vision. Eye 2022, 37, 797–808. [Google Scholar] [CrossRef] [PubMed]
- Monroe, E.J.; Chick, J.F.B.; Stacey, A.W.; Millard, N.E.; Geyer, J.R.; Ramoso, L.R.; Ghodke, B.V.; Hallam, D.K. Radiation dose reduction during intra-arterial chemotherapy for retinoblastoma: A retrospective analysis of 96 consecutive pediatric interventions using five distinct protocols. Pediatr. Radiol. 2021, 51, 649–657. [Google Scholar] [CrossRef] [PubMed]
- Baltussen, A.; Kindler, C.H. Citation classics in anesthetic journals. Anesth Analg. 2004, 98, 443–451. [Google Scholar] [CrossRef] [Green Version]
- Murphree, A.L. Intraocular retinoblastoma: The case for a new group classification. Ophthalmol. Clin. North Am. 2005, 18, 41-viii. [Google Scholar] [CrossRef]
- Shields, C.L.; Mashayekhi, A.; Au, A.K.; Czyz, C.; Leahey, A.; Meadows, A.T.; Shields, J. AThe International Classification of Retinoblastoma predicts chemoreduction success. Ophthalmology 2006, 113, 2276–2280. [Google Scholar] [CrossRef]
- Shields, C.L.; Shields, J.A.; Needle, M.; De Potter, P.; Kheterpal, S.; Hamada, A.; Meadows, A.T. Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma. Ophthalmology 1997, 104, 2101–2111. [Google Scholar] [CrossRef]
- Kingston, J.E.; Hungerford, J.L.; Madreperla, S.A.; Plowman, P.N. Results of combined chemotherapy and radiotherapy for advanced intraocular retinoblastoma. Arch. Ophthalmol. 1996, 114, 1339–1343. [Google Scholar] [CrossRef]
- Yamane, T.; Kaneko, A.; Mohri, M. The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma. Int. J. Clin. Oncol. 2004, 9, 69–73. [Google Scholar] [CrossRef]
- Broaddus, E.; Topham, A.; Singh, A.D. Survival with retinoblastoma in the USA: 1975–2004. Br. J. Ophthalmol. 2009, 93, 24–27. [Google Scholar] [CrossRef]
- Chantada, G.; Fandiño, A.; Manzitti, J.; Urrutia, L.; Schvartzman, E. Late diagnosis of retinoblastoma in a developing country. Arch. Dis. Child. 1999, 80, 171–174. [Google Scholar] [CrossRef]
Data | Details |
---|---|
Number of citations | Includes the mean number of citations per year since publication (The Web of Science database was searched between the years 1970 and 2018). |
Journal details | The journal name, impact factor, quartile, the year of publication, and the publication language |
Authors details | The names and number of authors, the country and continent of origin of the first and last authors, and the affiliations of the first and last authors |
Type and methodology of article | The type of article based on the different types of articles listed in JAMA Ophthalmology Journal*, the type of research methodology, and the type of study (single or multicenter study) |
Number of participants | The number of patients included (when applicable) |
Topics | Incidence, genetics, classification system, pathology, diagnosis and screening, treatment, trilateral retinoblastoma, secondary tumors, and metastasis |
Funding of study | External funding for the research |
Name of Institute | Number of Articles |
---|---|
Wills Eye Institute and Thomas Jefferson University, Philadelphia, PA, USA | 21 |
New York Hospital-Cornell Medical Center, New York, NY, USA | 7 |
Armed Forces Institute of Pathology, Washington, DC, USA | 4 |
Memorial Sloan Kettering, New York, NY, USA | 4 |
Hospital JP Garrahan, Buenos Aires, Argentina | 4 |
University of Oxford, Oxford, England | 4 |
Helsinki University Central Hospital, Helsinki, Finland | 3 |
Children’s Hospital, Los Angeles, CA, USA | 3 |
University of Texas, Houston, TX, USA | 3 |
University of Southern California, Los Angeles, CA, USA | 3 |
National Cancer Institute, Bethesda, MD, USA | 3 |
Institut Curie, Paris, France | 3 |
Harvard University, Cambridge, MA, USA | 3 |
VU University Medical Center, Amsterdam, The Netherlands | 2 |
Cleveland Clinic, Cleveland, OH, USA | 2 |
The George Washington University Medical Center, Washington, DC, USA | 2 |
Vrije Universiteit, Amsterdam, The Netherlands | 2 |
University of Toronto, Toronto, ON, Canada | 2 |
Free University, Amsterdam, The Netherlands | 2 |
Author Name | Number of Publications | Author Name | Number of Publications |
---|---|---|---|
J.A., Shields MD | 19 | C.M., Frank MD | 3 |
C.L., Shields MD | 19 | A.G. Knudson MD, PhD | 3 |
D.H., Abramson MD | 14 | L., Desjardins MD | 3 |
A., Meadows MD | 8 | S.G., Honavar MD | 3 |
C., Rodriguez-Galindo MD | 7 | H., Demirci MD | 3 |
G., Chantada MD | 7 | T., Kivelä MD | 3 |
I., Dunkel, MD | 6 | E., Schvartzman MD, PhD | 3 |
S.M., Imhof MD, PhD | 5 | M.G., Wilson MD | 3 |
J., Cater PhD | 5 | C.B.G., Antoneli MD | 3 |
A.D., Singh MD | 5 | M.O., Ts’O MD | 3 |
A.C., Moll MD, PhD | 5 | L.E., Zimmerman MD | 3 |
G.J., Draper MD | 4 | D.J., Kuik M.Sc | 3 |
P., De Potter MD | 4 | E. Quintana DO | 3 |
B., Haik MD | 4 | B., Gallie MD | 3 |
B.M., Sanders MD | 4 | J., Michon MD | 3 |
F., Doz MD | 4 | M.T., De Davila MD | 3 |
K. E.W.P, Tan MD | 4 | J.W., Koten MD, PhD | 3 |
R.M., Ellsworth MD | 4 | W., Den-Otter MD | 3 |
A.L., Murphree MD | 3 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Shemesh, R.; Sandler, H.; Dichter, S.; Fabian, I.D.; Mezer, E.; Wygnanski-Jaffe, T. The Most-Cited Articles on Retinoblastoma: A Fifty-Year Perspective. Vision 2023, 7, 33. https://doi.org/10.3390/vision7020033
Shemesh R, Sandler H, Dichter S, Fabian ID, Mezer E, Wygnanski-Jaffe T. The Most-Cited Articles on Retinoblastoma: A Fifty-Year Perspective. Vision. 2023; 7(2):33. https://doi.org/10.3390/vision7020033
Chicago/Turabian StyleShemesh, Rachel, Hunter Sandler, Sarah Dichter, Ido Didi Fabian, Eedy Mezer, and Tamara Wygnanski-Jaffe. 2023. "The Most-Cited Articles on Retinoblastoma: A Fifty-Year Perspective" Vision 7, no. 2: 33. https://doi.org/10.3390/vision7020033